These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1695630)

  • 1. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
    Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
    Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
    J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
    Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
    Hock J; Vogel R; Linke RP; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties.
    Kaufmann J; Haasemann M; Modrow S; Müller-Esterl W
    J Biol Chem; 1993 Apr; 268(12):9079-91. PubMed ID: 7682558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
    Tait JF; Fujikawa K
    J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
    Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
    J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
    Scarsdale JN; Harris RB
    J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
    You JL; Scarsdale JN; Harris RB
    J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
    Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
    Reddigari SR; Kaplan AP
    Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
    Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
    J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.
    Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W
    Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 17. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
    You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
    Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes.
    Henderson LM; Figueroa CD; Muller-Esterl W; Stain A; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 1)():590-4. PubMed ID: 1466300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T; Kato H; Maeda H; Iwanaga S
    J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of cDNAs for mouse low-molecular-weight and high-molecular-weight prekininogens.
    Takano M; Kondo J; Yayama K; Otani M; Sano K; Okamoto H
    Biochim Biophys Acta; 1997 May; 1352(2):222-30. PubMed ID: 9199253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.